Oncomed Pharma
(OMED)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2016 | 03-2016 | 12-2015 | 09-2015 | 06-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -54,902 | -27,213 | -85,407 | -60,629 | -36,149 |
| Depreciation Amortization | 880 | 434 | 1,643 | 1,216 | 790 |
| Accounts receivable | 68,678 | 69,391 | -70,657 | -273 | 12 |
| Accounts payable and accrued liabilities | -2,209 | N/A | 2,212 | -906 | 1,736 |
| Other Working Capital | 61,159 | 59,669 | -2,140 | -5,311 | -1,432 |
| Other Operating Activity | -60,522 | -66,396 | 79,211 | 8,494 | 3,056 |
| Operating Cash Flow | $13,084 | $35,885 | $-75,138 | $-57,409 | $-31,987 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -14,779 | 10,010 | 85,030 | 60,045 | 39,977 |
| PPE Investments | -698 | -516 | -1,364 | -1,178 | -1,035 |
| Investing Cash Flow | $-15,477 | $9,494 | $83,666 | $58,867 | $38,942 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 1,720 | 740 | 1,778 | 1,684 | 1,162 |
| Financing Cash Flow | $1,720 | $740 | $1,778 | $1,684 | $1,162 |
| Beginning Cash Position | 38,444 | 38,444 | 28,138 | 28,138 | 28,138 |
| End Cash Position | 37,771 | 84,563 | 38,444 | 31,280 | 36,255 |
| Net Cash Flow | $-673 | $46,119 | $10,306 | $3,142 | $8,117 |
| Free Cash Flow | |||||
| Operating Cash Flow | 13,084 | 35,885 | -75,138 | -57,409 | -31,987 |
| Capital Expenditure | -698 | -516 | -1,364 | -1,178 | -1,035 |
| Free Cash Flow | 12,386 | 35,369 | -76,502 | -58,587 | -33,022 |